# Neuralink Blindsight Receives FDA Breakthrough Device Designation

> fda · REPORTED · 2025-06-01

The FDA granted Breakthrough Device Designation to Neuralink's Blindsight vision-restoration implant in June 2025, accelerating the regulatory review timeline from years to months for key submissions.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.neurapod.com/blog/when-neuralink-available-public

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.